Staska Phaimaceuticals, fuc
FDA inspection history in Bennet, Nebraska, 2024 to 2026
- 2
- Form 483s
- 1
- Warning letter
Every document, by year
- Form 483
- Warning letter
2024: one Form 483; 2025: one warning letter; 2026: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2024–26Two Form 483s and one warning letter, at Bennet, Nebraska.
- 2024The longest 483 on file: 9 observations over 9 pages at Bennet, Nebraska.
Cited most
Across all Staska Phaimaceuticals, fuc observations on file
- 21 CFR 211.42Design and construction features3
- 21 CFR 211.192Production record review2
- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.160(b)General requirements1
The complete Staska Phaimaceuticals, fuc file.
All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Bennet, Nebraska
Two Form 483s and one warning letter · 2024 to 2026 · 12 observations
Latest: Form 483, Feb 20, 2026 →
Documents
3 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2026-02-20 | 483 Form 483 | Bennet, Nebraska | 3 | $99 |
| 2025-05-05 | Warning letter Warning letter | Bennet, Nebraska | — | $99 |
| 2024-09-26 | 483 Form 483 | Bennet, Nebraska | 9 | $99 |
Investigators on these documents
FEI number 3017473850 · most recent document Feb 20, 2026
About Staska Phaimaceuticals, fuc
How many FDA Form 483s has Staska Phaimaceuticals, fuc received?
FDA Intel has 2 Form 483s on file for Staska Phaimaceuticals, fuc; the most recent is dated Feb 20, 2026.
When was Staska Phaimaceuticals, fuc last inspected by FDA?
The most recent FDA inspection document on file for Staska Phaimaceuticals, fuc is a Form 483 dated Feb 20, 2026, for the site in Bennet, Nebraska.
What did FDA cite at Staska Phaimaceuticals, fuc?
The regulations cited most in the observations on file for Staska Phaimaceuticals, fuc are 21 CFR 211.42 (Design and construction features), 3 times; 21 CFR 211.192 (Production record review), 2 times; 21 CFR 211.100 (Written procedures; deviations), 1 time.
Has Staska Phaimaceuticals, fuc received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for Staska Phaimaceuticals, fuc; the most recent is dated May 5, 2025.